Fingerprint
Dive into the research topics where William Nowlin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Assessing patient risk, benefit and outcomes in drug development: An observational study of regorafenib clinical trials
Dennis, B., Bratten, C., Hughes, G. K., Peña, A. M., McIntire, R., Ladd, C., Gardner, B., Nowlin, W., Livingston, R., Tuia, J., Haslam, A., Prasad, V. & Vassar, M., 19 Mar 2024, In: BMJ Oncology. 3, 1, e000229.Research output: Contribution to journal › Article › peer-review
Open Access -
Duodenal Perforation From IVC Filter Migration
Riley, K., Magana, F., Harris, A., Turner, N., Nowlin, W., Carroll, A., Kostal, B. & Crawford, A., 12 Dec 2024, In: Oklahoma State Medical Proceedings. 8, 3Research output: Contribution to journal › Article › peer-review
Open Access -
Microcytic Anemia in the Setting of Helminth Infection
Riley, K., Magana, F., Carroll, A., Nowlin, W., Harris, A. & Raghuraman, V., 12 Dec 2024, In: Oklahoma State Medical Proceedings. 8, 3Research output: Contribution to journal › Article › peer-review
Open Access -
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Regorafenib Clinical Trials
Dennis, B., Bratten, C., Hughes, G., Peña, A., McIntire, R., Ladd, C., Gardner, B., Nowlin, W., Livingston, R., Tuia, J., Haslam, A., Prasad, V. & Vassar, M., 21 Jul 2023.Research output: Contribution to conference › Poster › peer-review
Open AccessFile52 Downloads (Pure) -
Publication Trends among Medical Students, Urology Residents, and Urologists
Johnson, B., Bruns, M., Nowlin, W., Johnson, A., Breyer, B. & Vassar, M., 2 Oct 2021, p. 317.Research output: Contribution to conference › Poster › peer-review
Press/Media
-
Research from Oklahoma State University Center for Health Sciences in the Area of Drug Development Described (Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trials)
Vassar, M., Hughes, G. & Nowlin, W.
11/06/24
1 item of Media coverage
Press/Media